Clinical Trial Update: An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device (bRIGHT)

View source ↗

Summary

An observational real-world study evaluating the Abbott TriClip device for severe tricuspid valve regurgitation, currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Valve Regurgitation

Drugs mentioned

• TriClip

Snippet

Sponsor: Abbott Medical Devices | Conditions: Tricuspid Valve Regurgitation | Status: ACTIVE_NOT_RECRUITING